Skip navigation

Alfresa Holdings Corp.

Pharmaceuticals
Japan
2016 Revenue (US$ Millions)$21,819
Revenue Growth (%)-0.95%
Net Income (US$ Millions)$264
Earnings Per Share (US$)NA
EPS Growth Rate (%)NA
Profit Margin1.21%
Total Equity (US$ Millions)$3,354
Return on Equity (%)8.43%
Long Term Debt (US$ Millions)$11
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$10,738
Current Assets (US$ Millions)$8,232
Current Liabilities (US$ Millions)$6,965
Cost of Goods Sold (US$ Millions)$20,258
Inventory Turnover17.86